Home › Rhabdomyosarcoma › Texas › Houston
Rhabdomyosarcoma clinical trials in Houston, TX
5 studies for Rhabdomyosarcoma are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
RecruitingPhase 1
- University of Texas - MD Anderson Cancer Center, Houston
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
RecruitingPhase 1/2
- Texas Children's Hospital, Houston
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
RecruitingPhase 1
- Texas Children's Hospital, Houston
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
RecruitingPhase 1
- Texas Children's Hospital, Houston
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
RecruitingPhase 1
- Houston Methodist Hospital, Houston
Rhabdomyosarcoma trials in other cities
- Memphis, TN6 studies
- Washington, DC5 studies
- Salt Lake City, UT4 studies
- Birmingham, AL3 studies
- Dallas, TX3 studies
- Milwaukee, WI3 studies
- Philadelphia, PA3 studies
- Mountain View, CA3 studies
- The Bronx, NY3 studies
- Aurora, CO3 studies
- Boston, MA3 studies
- Baltimore, MD3 studies
Other studies in Houston
- Non-Small Cell Lung Cancer143 studies
- Breast Cancer126 studies
- Cancer (all types)124 studies
- Colorectal Cancer101 studies
- Metastatic Cancer100 studies
- Ovarian Cancer90 studies
- Acute Myeloid Leukemia88 studies
- Lung Cancer78 studies
- Prostate Cancer73 studies
- Endometrial Cancer69 studies
- Melanoma61 studies
- Pancreatic Cancer59 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.